COVID‐19–Associated Reversible Cerebral Vasoconstriction Syndrome: A Rare Case of Secondary Thunderclap Headache
Case Reports in Neurological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crnm/4136897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Neurological Medicine, online erschienen am 16.03.2026. Verfasst von Seraj Makkawi und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, ksau-hs.edu.sa. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Reversible cerebral vasoconstriction syndrome (RCVS) is a condition characterized by severe, sudden headaches, and transient cerebral artery constriction, often triggered by medications, physical activities, or comorbidities. Recent studies have linked RCVS to SARS‐CoV‐2 infection. This case report presents a novel instance of RCVS with nonaneurysmal subarachnoid hemorrhage (SAH) following COVID‐19. A 44‐year‐old female with COVID‐19 presented with a sudden, severe headache, confusion, dizziness, and photophobia. Imaging revealed extensive SAH and hydrocephalus. Despite the absence of classic RCVS triggers, a cerebral angiogram showed multifocal vasospasms in both anterior and posterior circulations which later resolved on repeat cerebral angiography. The patient’s condition improved with external ventricular drainage followed by symptomatic treatment. She was diagnosed with RCVS after achieving an RCVS 2 score of seven points. She had a final modified Rankin scale of zero at 40‐month follow‐up. This case highlights the potential association between COVID‐19 and RCVS, even in the absence of common triggers. While causality cannot be definitively established, the temporal relationship and plausible biological mechanisms warrant further investigation. This report underscores the importance of considering RCVS in patients with neurological symptoms following COVID‐19 and contributes to the understanding of the virus’s impact on the vasculature.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, ksau-hs.edu.sa.
- King Abdullah International Medical Research Center, Jeddah, Saudi Arabia, kaimrc.med.sa.
- Department of Neurology, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia.
- Department of Medical Imaging, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia.
ORCID-Profile: Seraj Makkawi, Osama Khojah
Zitieren
APA
Makkawi, S., Khojah, O., Alsalmi, M., Alturaifi, A., Ibrahim, B., & Alshamy, A. (2026). COVID‐19–Associated Reversible Cerebral Vasoconstriction Syndrome: A Rare Case of Secondary Thunderclap Headache. Case Reports in Neurological Medicine, 2026(1). https://doi.org/10.1155/crnm/4136897
Vancouver
Makkawi S, Khojah O, Alsalmi M, Alturaifi A, Ibrahim B, Alshamy A. COVID‐19–Associated Reversible Cerebral Vasoconstriction Syndrome: A Rare Case of Secondary Thunderclap Headache. Case Reports in Neurological Medicine. 2026;2026(1). doi:10.1155/crnm/4136897
BibTeX
@article{Makkawi2026,
author = {Makkawi, Seraj and Khojah, Osama and Alsalmi, Mohammed and Alturaifi, Adilah and Ibrahim, Bader and Alshamy, Abdulrahman},
title = {COVID‐19–Associated Reversible Cerebral Vasoconstriction Syndrome: A Rare Case of Secondary Thunderclap Headache},
journal = {Case Reports in Neurological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crnm/4136897}
}
EUVIMED